EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Tumor Potential of Selective L-Type Amino Acid Transporter (LAT1) Inhibitor, JPH203, in Patient-Derived Canine Bladder Cancer Organoids

Ting-Wei Yu iD, Minami Kawahashi, Fumiya Goda, Ami Kanaya, Mohamed Elbadawy iD, Hitoshi Endou, Shoichiro Ide, Hideyuki Yamawaki, Masahiro Kaneda iD, Amira Abugomaa iD, Tsuyoshi Uchide, Tatsuya Usui und 1 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ting-Wei Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 3-5…. Hauptthemen laut MEDLINE: Large Neutral Amino Acid-Transporter 1, Urinary Bladder Neoplasms, Organoids, Antineoplastic Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CODEC CHEMICAL CO LTD, Codec Chemical Co., Ltd., Tokyo, Japan, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

L-type amino acid transporter 1 (LAT1), which controls the neutral amino acid uptake across the cell membranes, has been frequently overexpressed in various human cancers. Overexpression of LAT1 is associated with higher proliferation and shorter patient survival in tumors. Here, upregulated LAT1 expression was observed in patient-derived canine bladder cancers (BCs), and a small-molecule LAT1 inhibitor (JPH203) successfully reduced BC tumor growth both in vitro and in vivo. Patient-derived cancer cells were collected from dogs with naturally occurring tumors at veterinary clinics in Japan, and the 2.5D cancer organoid culture system was generated following our previous studies. Compared with other canine cancers or normal bladder cells, the increased LAT1 expression was observed in 2 strains of BC organoids. JPH203 inhibited boronophenylalanine (BPA) uptake activity by more than 90% and suppressed cell proliferation dose-dependently. Deprivation of BPA uptake activity by JPH203 also regulated the phosphorylation of mTOR-related proteins. Furthermore, intraperitoneal administration of JPH203 decreased the growth and tumor weight of BC organoid-derived xenograft in immunodeficient mice with an induction of apoptosis and a decrease in LAT1 expression compared to vehicle-administered mice. Therefore, the present study demonstrates that JPH203 exerts anti-tumor effects in canine BC through modulation of the mTOR signaling pathway and supports further investigation of LAT1-targeted therapy for canine BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Large Neutral Amino Acid-Transporter 1Urinary Bladder NeoplasmsOrganoidsAntineoplastic AgentsDog DiseasesAnimalsDogsCell ProliferationTOR Serine-Threonine KinasesHumansCell Line, TumorMiceXenograft Model Antitumor AssaysFemaleGene Expression Regulation, NeoplasticBenzoxazolesTyrosine

Stichwörter der Autor:innen

JPH203L-type amino acid transportercaninemTOR pathwayurothelial carcinoma

Substanzen

Large Neutral Amino Acid-Transporter 1Antineoplastic AgentsTOR Serine-Threonine Kinases2-amino-3-(4-((5-amino-2-phenylbenzo(d)oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acidBenzoxazolesTyrosine

Autor:innen und Institutionen

  • Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu 183-8509, Japan.
  • Laboratory of Veterinary Molecular Pathology and Therapeutics, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu 183-8509, Japan.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh 13736, Egypt.
  • Codec Chemical Co., Ltd., 1-1-4, Kanda, Ogawa-Machi, Chiyoda-ku 101-0052, Japan.
  • Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, 35-1 Higashi 23 ban-cho, Towada 034-8628, Japan.
  • Laboratory of Veterinary Anatomy, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu 183-8509, Japan.

ORCID-Profile: Ting-Wei Yu, Mohamed Elbadawy, Masahiro Kaneda, Amira Abugomaa

Förderung

  • CODEC CHEMICAL CO LTD
  • Codec Chemical Co., Ltd., Tokyo, Japan
  • JSPS KAKENHI

Zitieren

APA

Yu, T. W., Kawahashi, M., Goda, F., Kanaya, A., Elbadawy, M., Endou, H., Ide, S., Yamawaki, H., Kaneda, M., Abugomaa, A., Uchide, T., Usui, T., & Sasaki, K. (2026). Anti-Tumor Potential of Selective L-Type Amino Acid Transporter (LAT1) Inhibitor, JPH203, in Patient-Derived Canine Bladder Cancer Organoids. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177681

Vancouver

Yu TW, Kawahashi M, Goda F, Kanaya A, Elbadawy M, Endou H, et al. Anti-Tumor Potential of Selective L-Type Amino Acid Transporter (LAT1) Inhibitor, JPH203, in Patient-Derived Canine Bladder Cancer Organoids. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177681

BibTeX
@article{Yu2026,
  author = {Yu, Ting-Wei and Kawahashi, Minami and Goda, Fumiya and Kanaya, Ami and Elbadawy, Mohamed and Endou, Hitoshi and Ide, Shoichiro and Yamawaki, Hideyuki and Kaneda, Masahiro and Abugomaa, Amira and Uchide, Tsuyoshi and Usui, Tatsuya and Sasaki, Kazuaki},
  title = {Anti-Tumor Potential of Selective L-Type Amino Acid Transporter (LAT1) Inhibitor, JPH203, in Patient-Derived Canine Bladder Cancer Organoids},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177681}
}
Kostenlos starten →